MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sultatos, L. G.
Right arrow Articles by Murphy, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sultatos, L. G.
Right arrow Articles by Murphy, S. D.

The interaction of the phosphorothioate insecticides chlorpyrifos and parathion and their oxygen analogues with bovine serum albumin

LG Sultatos, KM Basker, M Shao and SD Murphy

The distribution and subsequent toxicity of hazardous chemicals can be influenced by their interactions with plasma proteins. In the present study reversible binding of the phosphorothioate insecticides chlorpyrifos and parathion to fatty acid-free bovine serum albumin (BSA) was examined using the technique of equilibrium dialysis. Computer analyses of the binding data revealed that chlorpyrifos and parathion each bound reversibly to a single class of binding sites on BSA, with apparent KD values of 3.4 +/- 0.1 and 11.1 +/- 0.3 microM, respectively. Additionally, the maximal number of binding sites for each insecticide per molecule of BSA was one. Displacement studies using both chlorpyrifos and parathion indicated that each was a competitive inhibitor of the other's binding, suggesting that they were bound to the same site. Incubation of chlorpyrifos oxon or paraoxon with a 1% solution of BSA resulted in limited, EDTA-insensitive formation of 3,5,6-trichloro-2-pyridinol or p-nitrophenol, respectively. Pretreatment of BSA with 5 mM paraoxon, chlorpyrifos oxon, or 1 mM diisopropylfluorophosphate did not alter this activity, suggesting that these reactions resulted from an esterase-like capacity of BSA, and not from phosphorylation of BSA by these oxons.

Volume 26, Issue 1, pp. 99-104, 07/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 EndocrinologyHome page
C. De Vriese, M. Hacquebard, F. Gregoire, Y. Carpentier, and C. Delporte
Ghrelin Interacts with Human Plasma Lipoproteins
Endocrinology, May 1, 2007; 148(5): 2355 - 2362.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
E. S. Peeples, L. M. Schopfer, E. G. Duysen, R. Spaulding, T. Voelker, C. M. Thompson, and O. Lockridge
Albumin, a New Biomarker of Organophosphorus Toxicant Exposure, Identified by Mass Spectrometry
Toxicol. Sci., February 1, 2005; 83(2): 303 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
F. Eyer and P. Eyer
Enzyme-based assay for quantification of paraoxon in blood of parathion poisoned patients
Human and Experimental Toxicology, December 1, 1998; 17(12): 645 - 651.
[Abstract] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. Salvi, P.-A. Carrupt, J. M. Mayer, and B. Testa
Esterase-like Activity of Human Serum Albumin Toward Prodrug Esters of Nicotinic Acid
Drug Metab. Dispos., April 1, 1997; 25(4): 395 - 398.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics